These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 11991997

  • 1. Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver.
    Zhang HG, Xie J, Xu L, Yang P, Xu X, Sun S, Wang Y, Curiel DT, Hsu HC, Mountz JD.
    J Virol; 2002 Jun; 76(11):5692-700. PubMed ID: 11991997
    [Abstract] [Full Text] [Related]

  • 2. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
    Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN.
    J Immunol; 2001 Aug 01; 167(3):1347-52. PubMed ID: 11466352
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
    Shetty S, Gladden JB, Henson ES, Hu X, Villanueva J, Haney N, Gibson SB.
    Apoptosis; 2002 Oct 01; 7(5):413-20. PubMed ID: 12207174
    [Abstract] [Full Text] [Related]

  • 4. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
    Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, Cocco L, Zauli G, Secchiero P, Manzoli FA, Vitale M.
    Blood; 2004 Oct 15; 104(8):2418-24. PubMed ID: 15205263
    [Abstract] [Full Text] [Related]

  • 5. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
    Shin EC, Ahn JM, Kim CH, Choi Y, Ahn YS, Kim H, Kim SJ, Park JH.
    Int J Cancer; 2001 Jul 15; 93(2):262-8. PubMed ID: 11410875
    [Abstract] [Full Text] [Related]

  • 6. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
    Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace AJ, el-Deiry WS.
    Cancer Res; 1998 Apr 15; 58(8):1593-8. PubMed ID: 9563466
    [Abstract] [Full Text] [Related]

  • 7. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5.
    Kim H, Kim EH, Eom YW, Kim WH, Kwon TK, Lee SJ, Choi KS.
    Cancer Res; 2006 Feb 01; 66(3):1740-50. PubMed ID: 16452234
    [Abstract] [Full Text] [Related]

  • 8. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
    Ishikawa E, Nakazawa M, Yoshinari M, Minami M.
    J Virol; 2005 Jun 01; 79(12):7658-63. PubMed ID: 15919918
    [Abstract] [Full Text] [Related]

  • 9. The combination of TRAIL treatment and cancer cell selective expression of TRAIL-death receptor DR4 induces cell death in TRAIL-resistant cancer cells.
    Choi E, Kim Y, Kim K.
    Yonsei Med J; 2006 Feb 28; 47(1):55-62. PubMed ID: 16502485
    [Abstract] [Full Text] [Related]

  • 10. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N, Poulaki V, Mitsiades C, Tsokos M.
    Cancer Res; 2001 Mar 15; 61(6):2704-12. PubMed ID: 11289151
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.
    Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, Yagita H, Okumura K.
    J Exp Med; 2001 Mar 19; 193(6):661-70. PubMed ID: 11257133
    [Abstract] [Full Text] [Related]

  • 12. Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer.
    Ozawa F, Friess H, Kleeff J, Xu ZW, Zimmermann A, Sheikh MS, Büchler MW.
    Cancer Lett; 2001 Feb 10; 163(1):71-81. PubMed ID: 11163110
    [Abstract] [Full Text] [Related]

  • 13. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation.
    Jung EM, Park JW, Choi KS, Park JW, Lee HI, Lee KS, Kwon TK.
    Carcinogenesis; 2006 Oct 10; 27(10):2008-17. PubMed ID: 16613838
    [Abstract] [Full Text] [Related]

  • 14. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
    Kamohara H, Matsuyama W, Shimozato O, Abe K, Galligan C, Hashimoto S, Matsushima K, Yoshimura T.
    Immunology; 2004 Feb 10; 111(2):186-94. PubMed ID: 15027904
    [Abstract] [Full Text] [Related]

  • 15. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
    Mérino D, Lalaoui N, Morizot A, Schneider P, Solary E, Micheau O.
    Mol Cell Biol; 2006 Oct 10; 26(19):7046-55. PubMed ID: 16980609
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
    Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN.
    Cancer Res; 2001 Jan 15; 61(2):759-63. PubMed ID: 11212279
    [Abstract] [Full Text] [Related]

  • 17. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).
    Jung EM, Lim JH, Lee TJ, Park JW, Choi KS, Kwon TK.
    Carcinogenesis; 2005 Nov 15; 26(11):1905-13. PubMed ID: 15987718
    [Abstract] [Full Text] [Related]

  • 18. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC.
    Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS.
    Oncogene; 2004 Aug 12; 23(36):6083-94. PubMed ID: 15208670
    [Abstract] [Full Text] [Related]

  • 19. Modulation of death receptor pathways in oncology.
    de Vries EG, Timmer T, Mulder NH, van Geelen CM, van der Graaf WT, Spierings DC, de Hooge MN, Gietema JA, de Jong S.
    Drugs Today (Barc); 2003 Aug 12; 39 Suppl C():95-109. PubMed ID: 14988748
    [Abstract] [Full Text] [Related]

  • 20. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T.
    Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.